Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) | MicrobiomeTrials← Back to trialsNCT04652882
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2020-12-09Est. Completion: 2026-09
Enrollment target: 70 participants Locations- Vanda Investigational Site, Los Angeles, California, United States
- Vanda Investigational Site, Redwood City, California, United States
- Vanda Investigational Site, Aurora, Colorado, United States
- Vanda Investigational Site, Boston, Massachusetts, United States
- Vanda Investigational Site, St Louis, Missouri, United States
- Vanda Investigational Site, New Hyde Park, New York, United States
- Vanda Investigational Site, Cincinnati, Ohio, United States
- Vanda Investigational Site, Cleveland, Ohio, United States
- Vanda Investigational Site, Columbia, South Carolina, United States
- Vanda Investigational Site, San Antonio, Texas, United States
- Vanda Investigational Site, Sherman, Texas, United States
- Vanda Investigational Site, Innsbruck, Austria
- Vanda Investigational Site, Vienna, Austria
- Vanda Investigational Site, Berlin, Germany
- Vanda Investigational Site, Hamburg, Germany
- Vanda Investigational Site, Marburg, Germany
- Vanda Investigational Site, Schwerin, Germany
Other microbiome trials you might be interested in
End-stage Chronic Kidney Disease Treated With HemodialysisDepressive Disorders
Hemodialysis is an intensive treatment, with a lifestyle dictated by the organization of the dialysis center. This treat…
Annecy, FranceEst. completion Sep 15, 2028
Sleep DisturbancesDepression
Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alz…
Albany, United StatesCompleted May 10, 2024